146 related articles for article (PubMed ID: 36736453)
1. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
[TBL] [Abstract][Full Text] [Related]
2. Opsoclonus myoclonus ataxia syndrome following COVID-19 infection.
Ismail II; Kamel WA; Kilany A
Acta Neurol Belg; 2023 Apr; 123(2):715-716. PubMed ID: 35836090
[No Abstract] [Full Text] [Related]
3. Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
Urrea-Mendoza E; Okafor K; Ravindran S; Absher J; Chaubal V; Revilla FJ
Tremor Other Hyperkinet Mov (N Y); 2021 Feb; 11():7. PubMed ID: 33614199
[TBL] [Abstract][Full Text] [Related]
4. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
7. Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Emamikhah M; Babadi M; Mehrabani M; Jalili M; Pouranian M; Daraie P; Mohaghegh F; Aghavali S; Zaribafian M; Rohani M
J Neurovirol; 2021 Feb; 27(1):26-34. PubMed ID: 33492608
[TBL] [Abstract][Full Text] [Related]
8. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
9. Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and dengue virus co-infection.
do Rosário MS; Giovanetti M; de Jesus PAP; Farias DS; Faria NR; de Lima CPS; da Silva SP; Nunes MR; Alcantara LCJ; de Siqueira IC
Int J Infect Dis; 2018 Oct; 75():11-14. PubMed ID: 30076990
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to dendritic neuronal surface antigens in opsoclonus myoclonus ataxia syndrome.
Panzer JA; Anand R; Dalmau J; Lynch DR
J Neuroimmunol; 2015 Sep; 286():86-92. PubMed ID: 26298330
[TBL] [Abstract][Full Text] [Related]
11. Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-2.
Fernandes J; Puhlmann P
J Neurovirol; 2021 Jun; 27(3):501-503. PubMed ID: 33788141
[TBL] [Abstract][Full Text] [Related]
12. Opsoclonus-myoclonus syndrome following rotavirus gastroenteritis.
Gurkas E; Gucuyener K; Yılmaz U; Havalı C; Demir E
Pediatr Int; 2014 Dec; 56(6):e86-e87. PubMed ID: 25521990
[TBL] [Abstract][Full Text] [Related]
13. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
14. Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report.
Reinecke R; Reiländer A; Seiler A; Koch C; Voss M
BMC Neurol; 2022 Dec; 22(1):507. PubMed ID: 36581905
[TBL] [Abstract][Full Text] [Related]
15. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
[TBL] [Abstract][Full Text] [Related]
16. Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection.
Shah PB; Desai SD
Neurology; 2021 Jan; 96(1):33. PubMed ID: 33004603
[No Abstract] [Full Text] [Related]
17. Surgical considerations for neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: a series of 14 patients from a single institution.
Johnston WR; Hwang R; Mattei P
Pediatr Surg Int; 2022 Feb; 38(2):249-255. PubMed ID: 34549330
[TBL] [Abstract][Full Text] [Related]
18. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus-myoclonus syndrome attributable to West Nile encephalitis: a case report.
Bîrluţiu V; Bîrluţiu RM
J Med Case Rep; 2014 Jun; 8():232. PubMed ID: 24968889
[TBL] [Abstract][Full Text] [Related]
20. [Opsoclonus-myoclonus-ataxia syndrome: two anatomo-clinical case reports].
Gabaldon-Torres L; Fernandez-Dominguez J; Salas-Felipe J; Caminoa-Lizarralde A; Palomo-Ferrer F; Gutierrez-Molina M; Morales-Bastos C; de Sarria-Lucas MJ; Arpa-Gutierrez FJ
Rev Neurol; 2009 Feb 1-15; 48(3):137-40. PubMed ID: 19206061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]